Searching journal content for pheochromocytoma (as phrase) in full text.

Displaying results 1-10 of 216
For checked items
  1. ...gland pheochromocytoma, pancreatic, pancreatic neuroendocrine, parathyroid gland, thyroid, pituitary gland NCT02834013 Nivolumab II; not yet recruiting Anti-PD1 Neuroendocrine NCT02923934 Ipilimumab Anti-CTLA4 Ibrutinib II; recruiting Btk inhibitor Pancreatic, carcinoid NCT02575300 RO7009789 I ~~~
  2. .... Neuroendocrine tumours, Endocrine-Related Cancer 417 2004;11, 1-18 418 6 Brandi ML, Gagel RF, et al, 2001 Guidelines for diagnosis and therapy of MEN type 1 and 419 type 2. Journal Clinical Endocrinology and Metabolism 2001;86:5658-5671 420 7 Drr R, Lenders JWM et al, Pheochromocytoma update on disease ~~~
  3. ...), suggesting a possible interference by other analytes. 206 Despite these limitations, the sensitivity of the method is promising since Popovici et al. (Popovici 207 et al. 2014) showed values of 100 and 94% in pheochromocytoma/paraganglioma and GEP NENs, 208 respectively. A more recent study compared ~~~
  4. ...genetic lesions in a number of human cancers, including renal cell cancers, glioblastomas and pheochromocytomas. In recent studies, missense mutations in the succinate dehydrogenase (SDH) complex have also been proposed to cause differentiated thyroid cancer. In order to gain mechanistic insight ~~~
  5. ..., Australia; School of Cancer Medicine, La 18 Trobe University, Bundoora, VIC, Australia. 19 Running title: TERT rearrangements in pheochromocytomas 20 Keywords: TERT, pheochromocytoma, metastatic, whole genome sequencing, rearrangements 21 Word count (excluding abstract, references and figure legends): 3165 ~~~
  6. ...DOI: 10.1530/ERC-17-0359 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 24:11 Research Letter Y Dengetal. TMEM127 in pheochromocytoma and renal cancer association 10.1530/ERC-17-0359 Dear Editor, Germline mutations ~~~
  7. ...). 45 MTC can be the only manifestation in familial MTC (FMTC), can be associated with 46 pheochromocytoma (PC) and parathyroid adenoma/carcinoma in MEN2A, or with PC, 47 mucosal neuromas and marphanoid habitus in MEN2B. Activating mutations in the 48 REarranged during Transfection (RET) proto ~~~
  8. ...), follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC) (Lin et al. 2007), undifferentiated pheochromocytoma (Barbakadzeetal. 2014) and myeloma (Cohen et al. 2015) (Fig. 2). In human breast cancer cells, T4 induces proliferation nongenomically, requiring ERK1/ERK2 and phosphorylating ~~~
  9. characterized by primary hyperparathyroidism (PHPT) due to parathyroid gland hyperplasia, and functional or nonfunctional pancreatic neuroendocrine tumors (pNETs) and pituitary adenomas (Thakker et al. 2012). MEN2, a less common entity, is characterized by medullary thyroid carcinoma (MTC), pheochromocytoma ~~~
  10. ...pheochromocytoma . PNAS 107 18493 – 18498 . ( doi:10.1073/pnas.1003956107 ) ↵ Murai MJ , Chruszcz M , Reddy G , Grembecka J & Cierpicki T 2011 Crystal structure of menin reveals binding site for mixed-lineage leukemia (MLL) protein . Journal of Biological Chemistry 286 31742 – 31748 . ( doi:10.1 ~~~
For checked items